制药行业借助行为信号与 AI 原生 MCP 通道重构患者用药依从性
Redesigning Pharma Adherence Around Patient Behavioral Signals and AI-Native MCP Rails
药企做患者依从项目的人应该看看这篇：把 WHO 2003 年那 50% 依从率的老问题，拆成识别停药前信号、用 MCP 通道做即时响应的工程问题，思路跟普通提醒类患者 App 不一样。
世界卫生组织在 2003 年的报告中指出，发达国家长期治疗的平均依从率约为 50%。文章提出，AI 对依从性的最大贡献不是新药或新渠道，而是一套新模型：读取患者在停药前留下的行为信号，并在那一刻提供对应的支持。实现路径是用 AI 原生的 MCP（Model Context Protocol）通道连接患者触点，让支持动作由具体信号触发，而非定期群发提醒。作者强调，前提是药企先回答一个组织问题：在患者面前想扮演什么角色，否则信号识别再准也会退化成更聪明的打扰。
这篇文章的落点在制药企业的数字化运营：将停药前的"stop signals"嵌入依从性项目设计，用 MCP 作为系统间的协议层，而非再造一个患者 App。对做患者支持项目（PSP）和医药数字营销的团队来说，这提供了一套从信号到响应的工作流框架。
Redesigning Pharma Adherence Around Patient Behavioral Signals and AI-Native MCP Rails
AI’s biggest contribution to adherence can be a new model: reading the signals patients leave before they stop, and responding with support built for that moment, but only if pharma decides who it wants to be to that patient. In 2003, the World Health Organization reported that adherence to long-term therapy in developed countries averages ... Read More
This report is categorized under AITOP's "Products" desk, focusing on US frontier AI labs and Silicon Valley technology leaders. Within our cross-regional analytical framework, it directly maps to AI developer toolchains, coding agents, and engineering workflows. Key entities and technical topics under continuous tracking include MCP/工具, 制药数字化, 患者依从性, 行为信号.
Source attribution: curated from HIT Consultant (@Fred Pennic).
